PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

Item
http://www.wikidata.org/entity/Q38970138
Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice.History and future technical innovation in positron emission tomography.Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer.Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.Current status of theranostics in prostate cancer.Radiotheranostics in Cancer Diagnosis and Management.Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies.Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.Effect of Carbohydration on the Theranostic Tracer PSMA I&TSynthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity
P2860

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

Item
http://www.wikidata.org/entity/Q38970138
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
PSMA-Based Radioligand Therapy ...... d Berka Experience Since 2013.
@en
type
label
PSMA-Based Radioligand Therapy ...... d Berka Experience Since 2013.
@en
prefLabel
PSMA-Based Radioligand Therapy ...... d Berka Experience Since 2013.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
PSMA-Based Radioligand Therapy ...... d Berka Experience Since 2013.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698